EXAS vs SBSI · rev $2.76B vs P/E 14, rev $206.2M
EXACT Sciences Corporation (EXAS) versus Southside Bancshares, Inc. (SBSI) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Southside Bancshares, Inc. (SBSI) is a banks - regional company listed on NYSE.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported SBSI revenue for 2026-06-30 was $206.2M. Net income was $50.1M. SBSI currently screens at market cap $986.3M and trailing P/E 14.0.
EXAS currently screens at market cap $20.03B. SBSI currently screens at market cap $986.3M and trailing P/E 14.0.
Not investment advice. Open the EXAS and SBSI stock pages for the full models.
Not investment advice.